These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1552 related articles for article (PubMed ID: 18443954)

  • 1. Expression of multidrug-resistance-related proteins P-glycoprotein, glutathione-S-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma.
    Shi H; Lu D; Shu Y; Shi W; Lu S; Wang K
    Cancer Invest; 2008 May; 26(4):344-51. PubMed ID: 18443954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of multidrug resistance-related proteins p-glycoprotein, glutathione-s-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma.
    Shi H; Lu D; Shu Y; Shi W; Lu S; Wang K
    Hepatogastroenterology; 2008; 55(86-87):1530-6. PubMed ID: 19102336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Expression and significance of MRP, GST-pi, Topo IIalpha, and LRP in gastric carcinoma].
    Yu DQ; Yi YF
    Ai Zheng; 2003 May; 22(5):496-9. PubMed ID: 12753710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of multidrug resistance-related markers in gastric cancer.
    Fan K; Fan D; Cheng LF; Li C
    Anticancer Res; 2000; 20(6C):4809-14. PubMed ID: 11205224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression and implication of Pgp, MRP, LRP, GST-pi, Topo II alpha in tongue squamous cell carcinoma].
    Leng WD; Wang DZ; Feng G; He J
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2004 Feb; 22(1):23-5. PubMed ID: 15017692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multidrug resistance-associated biomarkers PGP, GST-pi, Topo-II and LRP as prognostic factors in primary ovarian carcinoma.
    Lu D; Shi HC; Wang ZX; Gu XW; Zeng YJ
    Br J Biomed Sci; 2011; 68(2):69-74. PubMed ID: 21706917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of P-gp, MRP, LRP, GST-π and TopoIIα and intrinsic resistance in human lung cancer cell lines.
    Wang J; Zhang J; Zhang L; Zhao L; Fan S; Yang Z; Gao F; Kong Y; Xiao GG; Wang Q
    Oncol Rep; 2011 Nov; 26(5):1081-9. PubMed ID: 21805041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Multidrug resistance and its relationship with neuroendocrine differentiation in non-small cell lung carcinoma].
    Yu SP; Xiong YY; Tian SF
    Zhonghua Jie He He Hu Xi Za Zhi; 2003 Mar; 26(3):165-8. PubMed ID: 12816683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential expression of the drug resistance markers DNA topoisomerase II alpha and glutathione S-transferase-pi in the histological compartments of Wilms' tumors.
    Granzen B; Efferth T; Keller U; Beniers AJ; Mertens R; Jakse G; Füzesi L
    Anticancer Res; 2001; 21(1B):771-6. PubMed ID: 11299842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of mutant p53 and of the multidrug resistant proteins P-glycoprotein and glutathione S-transferase-pi correlated in colorectal adenocarcinoma.
    Zhang Z; Deng X; Ren X; Zhang B; Chen X; Yang J; Ding H; Sui J; Song X
    Scand J Gastroenterol; 2010 Aug; 45(7-8):925-34. PubMed ID: 20377486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topoisomerase II alpha expression in squamous cell carcinomas of the head and neck.
    Stathopoulos GP; Kapranos N; Manolopoulos L; Papadimitriou C; Adamopoulos G
    Anticancer Res; 2000; 20(1A):177-82. PubMed ID: 10769652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. P-glycoprotein (PGP), and not lung resistance-related protein (LRP), is a negative prognostic factor in secondary leukemias.
    Damiani D; Michieli M; Ermacora A; Candoni A; Raspadori D; Geromin A; Stocchi R; Grimaz S; Masolini P; Michelutti A; Scheper RJ; Baccarani M
    Haematologica; 1998 Apr; 83(4):290-7. PubMed ID: 9592977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of MDR1, LRP, MRP, and topoisomerase IIalpha gene mRNA transcripts before and after interferon-alpha, and correlation with the mRNA expression level of the telomerase subunits hTERT and TEP1 in five unselected human melanoma cell lines.
    Miracco C; Maellaro E; Pacenti L; Del Bello B; Valentini MA; Rubegni P; Pirtoli L; Volpi C; Santopietro R; Tosi P
    Int J Oncol; 2003 Jul; 23(1):213-20. PubMed ID: 12792796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression of P-gp, GST-pi and Topo II alpha in gastric and colorectal cancers and their clinical significance].
    Chen WY; Mao WM; Zhao L; Chen GP; Shu Y; Shen YF; Zhu XH; Xia Y
    Zhonghua Zhong Liu Za Zhi; 2005 Dec; 27(12):738-40. PubMed ID: 16483485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of multidrug resistance-related markers in primary neuroblastoma.
    Lu QJ; Dong F; Zhang JH; Li XH; Ma Y; Jiang WG
    Chin Med J (Engl); 2004 Sep; 117(9):1358-63. PubMed ID: 15377429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of TRAIL on the expression of multidrug resistant genes MDR1, LRP and GST-π in drug-resistant gastric cancer cell SGC7901/VCR.
    Zhang KG; Qin CY; Wang HQ; Wang JX; Wang QM
    Hepatogastroenterology; 2012; 59(120):2672-6. PubMed ID: 23178631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of lung resistance-related protein in transitional cell carcinoma of bladder.
    Zhu Y; Kong C; Zeng Y; Sun Z; Gao H
    Urology; 2004 Apr; 63(4):694-8. PubMed ID: 15072883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multidrug resistance-related phenotype and apoptosis-related protein expression in ovarian serous carcinomas.
    Yakirevich E; Sabo E; Naroditsky I; Sova Y; Lavie O; Resnick MB
    Gynecol Oncol; 2006 Jan; 100(1):152-9. PubMed ID: 16198399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of multidrug resistance gene-related proteins in the postoperative chemotherapy of gastric cancer.
    Yu P; Du Y; Yang L; Fan S; Wu J; Zheng S
    Int J Clin Exp Pathol; 2014; 7(11):7945-50. PubMed ID: 25550836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Markers of drug resistance in relapsing colon cancer.
    Lazaris AC; Kavantzas NG; Zorzos HS; Tsavaris NV; Davaris PS
    J Cancer Res Clin Oncol; 2002 Feb; 128(2):114-8. PubMed ID: 11862483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 78.